drugset / Trial / NCT00329069

The Role of Atorvastatin on Monocyte Function in Patients With Coronary Artery Disease and Hypercholesterolemia

NCT00329069

Completed 50 enrolled University of Ulm Pfizer · collab
RandomizedParallel-groupDouble-blindDiagnostic

Summary

The aim of this study is to determine, whether an intensified atorvastatin therapy can improve monocyte function in patients with coronary artery disease and hypercholesterolemia.

Timeline

Start
2002-05
Primary completion
Completion
2006-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 40 mg